Authors:
Layton, GT
Harris, SJ
Bland, FA
Lee, SR
Fearn, S
Kaleta, J
Wood, ML
Bond, A
Ward, G
Citation: Gt. Layton et al., Therapeutic effects of cysteine protease inhibition in allergic lung inflammation: Inhibition of allergen-specific T lymphocyte migration, INFLAMM RES, 50(8), 2001, pp. 400-408
Authors:
Penny, WF
Ben-Yehuda, O
Kuroe, K
Long, J
Bond, A
Bhargava, V
Peterson, JF
McDaniel, MR
Juliano, J
Witztum, JL
Ross, J
Peterson, KL
Citation: Wf. Penny et al., Improvement of coronary artery endothelial dysfunction with lipid-loweringtherapy: Heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein, J AM COL C, 37(3), 2001, pp. 766-774
Citation: J. Vandergriff et al., Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo, NEUROPHARM, 40(8), 2001, pp. 1003-1009
Authors:
Halvorsen, YDC
Bond, A
Sen, A
Franklin, DM
Lea-Currie, YR
Sujkowski, D
Ellis, PN
Wilkison, WO
Gimble, JM
Citation: Ydc. Halvorsen et al., Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: Biochemical, cellular, and molecular analysis, METABOLISM, 50(4), 2001, pp. 407-413
Citation: A. Bond et W. Jones, A host-guest complex of diaquabis-[1-hydroxy-2(1H)-pyridinethionato-O,S]magnesium(II) and 2,2 '-dithio-bis(pyridine N-oxide), ACT CRYST C, 56, 2000, pp. 436-437
Authors:
Akers, RJ
Bond, A
Buttery, RJ
Carolan, PG
Counsell, GF
Cunningham, G
Fielding, SJ
Gimblett, CG
Gryaznevich, M
Hastie, RJ
Helander, P
Hender, TC
Knight, PJ
Lashmore-Davies, CN
Maddison, GP
Martin, TJ
McClements, KG
Morris, AW
O'Brien, MR
Ribeiro, C
Roach, CM
Robinson, DC
Sykes, A
Voss, GM
Walsh, MJ
Wilson, HT
Zaitsev, FS
Citation: Rj. Akers et al., Steady state operation of spherical tokamaks, NUCL FUSION, 40(6), 2000, pp. 1223-1244
Authors:
O'Neill, MJ
Bogaert, L
Hicks, CA
Bond, A
Ward, MA
Ebinger, G
Ornstein, PL
Michotte, Y
Lodge, D
Citation: Mj. O'Neill et al., LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia, NEUROPHARM, 39(9), 2000, pp. 1575-1588
Authors:
Bond, A
Jones, NM
Hicks, CA
Whiffin, GM
Ward, MA
O'Neill, MF
Kingston, AE
Monn, JA
Ornstein, PL
Schoepp, DD
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist:Investigations into possible mechanism of action in vivo, J PHARM EXP, 294(3), 2000, pp. 800-809
Authors:
Hill, M
Beeson, D
Moss, P
Jacobson, L
Bond, A
Corlett, L
Newsom-Davis, J
Vincent, A
Willcox, N
Citation: M. Hill et al., Early-onset myasthenia gravis: A recurring T-cell epitope in the adult-specific acetylcholine receptor epsilon subunit presented by the susceptibility allele HLA-DR52a, ANN NEUROL, 45(2), 1999, pp. 224-231
Authors:
Bond, A
Ragumoorthy, N
Monn, JA
Hicks, CA
Ward, MA
Lodge, D
O'Neill, MJ
Citation: A. Bond et al., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia, NEUROSCI L, 273(3), 1999, pp. 191-194
Citation: C. Bass et al., Frequent attenders without organic disease in a gastroenterology clinic - Patient characteristics and health care use, GEN HOSP PS, 21(1), 1999, pp. 30-38